2CG.F NANOSPHERE HEA.SCIENCES
- Market cap
- EUR 113K
- P/E
- -
- P/B
- 2.03x
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2025.
Is 2CG.F undervalued?
Graham numberThe Graham number of NANOSPHERE HEA.SCIENCES cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
NANOSPHERE HEA.SCIENCES fundamental analysis
No fundamental analysis for NANOSPHERE HEA.SCIENCES yet.
NANOSPHERE HEA.SCIENCES stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About NANOSPHERE HEA.SCIENCES
NanoSphere Health Sciences Inc., a nano-biotechnology company, focuses on providing biologically active compounds in the United States and Canada. It offers NanoSphere Delivery System, a platform using nanotechnology in the biodelivery of supplements, nutraceuticals, and over-the-counter medications for the cannabis, pharmaceutical, animal health, and other industries. NanoSphere Health Sciences Inc. is headquartered in Vancouver, Canada.
Full company profileNANOSPHERE HEA.SCIENCES financial statements
NANOSPHERE HEA.SCIENCES annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -386K | -284K | -237K | -184K | -179K |
| EBITDA | - | -284K | -228K | 265K | -80.6K |
| Net Income | -356K | -282K | -228K | 263K | -84.8K |
| EPS | -0.03 | -0.03 | -0.02 | 0.03 | -0.01 |
| Balance Sheet | |||||
| Total Assets | 133K | 60.0K | 18.0K | 13.6K | 16.8K |
| Total Liabilities | 1.21M | 1.37M | 1.57M | 1.23M | 1.37M |
| Shareholders' Equity | -1.08M | -1.31M | -1.56M | -1.22M | -1.35M |
| Cash & Short-term Investments | 131K | 55.0K | 9.32K | 2.02K | 1.89K |
| Cash Flow | |||||
| Operating Cash Flow | -64.7K | -67.7K | -53.7K | -35.9K | -23.0K |
| Capital Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow | -64.7K | -67.7K | -53.7K | -35.9K | -23.0K |
| Ratios | |||||
| ROA | -268.9% | -469.2% | -1,269.3% | 1,937.1% | -503.3% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROA
- Return on assets: net income divided by total assets.
NANOSPHERE HEA.SCIENCES dividends
NANOSPHERE HEA.SCIENCES has not paid dividends in the last 5 fiscal years.
Last stock split: 1:20 on Jul 7, 2021.
Who owns NANOSPHERE HEA.SCIENCES
- Insiders 32.29%
- Institutions 0.00%
- Public & others 67.71%
- Shares outstanding 10.3M
- Free float 6.96M
NANOSPHERE HEA.SCIENCES company profile
- Company name
- NANOSPHERE HEA.SCIENCES
- Ticker
- 2CG.F
- ISIN
- CA63010P2098
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- Fiscal year end
- December
- Address
- 605 Robson Street, Vancouver, BC, Canada, BC V6B 5J3
- Phone
- 604 351 3351
- Website
- nanospherehealth.com
About NANOSPHERE HEA.SCIENCES
NanoSphere Health Sciences Inc., a nano-biotechnology company, focuses on providing biologically active compounds in the United States and Canada. It offers NanoSphere Delivery System, a platform using nanotechnology in the biodelivery of supplements, nutraceuticals, and over-the-counter medications for the cannabis, pharmaceutical, animal health, and other industries. NanoSphere Health Sciences Inc. is headquartered in Vancouver, Canada.
NANOSPHERE HEA.SCIENCES management
3- Mr. Michael Alexander IversonChairman of the Board & Interim CFO · born 1952
- Dr. Richard Clark Kaufman B.S., M.S., Ph.D.Co-Founder & Director · born 1950
- Mr. Toby LimCorporate Secretary & Independent Director